Open-Angle Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The open-angle glaucoma clinical trial market research report provides an overview of open-angle glaucoma clinical trials scenario. The report provides top line data relating to the clinical trials on open-angle glaucoma. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, the report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
Open-Angle Glaucoma Clinical Trials Market Segmentation by Regions and Countries
The key regions in the open-angle glaucoma clinical trials market are North America, Asia-Pacific, Europe, Middle East and Africa, and South and Central America. North America dominated the market with the highest number of clinical trials conducted.
In a country wise analysis, as of April 2022, the US has the highest number of open-angle glaucoma clinical trials, followed by Japan, India, Italy, Germany, Spain, China, Canada, France, and the UK.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada and Japan) countries, Japan has the highest proportion of open-angle glaucoma to ophthalmology clinical trials as of April 2022. Moreover, most of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey and Indonesia) countries, Mexico has the highest proportion of open-angle glaucoma to ophthalmology clinical trials as of April 2022. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Open-Angle Glaucoma Clinical Trials Analysis by Regions
For more regional insights into the open-angle glaucoma clinical trials market, download a free report sample
Open-Angle Glaucoma Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the open-angle glaucoma clinical trials market are company, institution, and the government. Out of them, company dominates the market.
Open-Angle Glaucoma Clinical Trials Market Analysis by Sponsor Types
For more sponsor type insights into the open-angle glaucoma clinical trials market, download a free report sample
Open-Angle Glaucoma Clinical Trials Market - Competitive Landscape
The leading sponsors in the open-angle glaucoma clinical trials market are Alcon Inc, AbbVie Inc, Santen Pharmaceutical Co Ltd, Aerie Pharmaceuticals Inc, Pfizer Inc, Merck & Co Inc, Bausch Health Companies Inc, Senju Pharmaceutical Co Ltd, Novartis AG, and Kowa Co Ltd. Out of them, Alcon Inc has conducted the highest number of open-angle glaucoma clinical trials.
Open-Angle Glaucoma Clinical Trials Market Analysis by Sponsors
To know more about the leading players in the open-angle glaucoma clinical trials market, download a free report sample
Open-Angle Glaucoma Clinical Trials Market Report Overview
Key Regions | North America, Asia-Pacific, Europe, Middle East and Africa, and South and Central America |
Key Countries | The US, Japan, India, Italy, Germany, Spain, China, Canada, France, and the UK |
Key Sponsor Types | Company, Institution, and the Government |
Leading Sponsors | Alcon Inc, AbbVie Inc, Santen Pharmaceutical Co Ltd, Aerie Pharmaceuticals Inc, Pfizer Inc, Merck & Co Inc, Bausch Health Companies Inc, Senju Pharmaceutical Co Ltd, Novartis AG, and Kowa Co Ltd |
Scope
- The report provides a snapshot of the global clinical trials landscape.
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.
- The Report provides enrollment trends for the past five years.
- Report provides latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
AbbVie Inc
Santen Pharmaceutical Co Ltd
Aerie Pharmaceuticals Inc
Pfizer Inc
Merck & Co Inc
Bausch Health Companies Inc
Kowa Co Ltd
Novartis AG
Senju Pharmaceutical Co Ltd
Table of Contents
Frequently asked questions
-
What are the key regions in the open-angle glaucoma clinical trials market?
The key regions in the open-angle glaucoma clinical trials market are North America, Asia-Pacific, Europe, Middle East and Africa, and South and Central America.
-
What are the key countries in the open-angle glaucoma clinical trials market?
The key countries in the open-angle glaucoma clinical trials market are the US, Japan, India, Italy, Germany, Spain, China, Canada, France, and the UK.
-
What are the key sponsor types in the open-angle glaucoma clinical trials market?
The key sponsor types in the open-angle glaucoma clinical trials market are company, institution, and the government.
-
Who are the leading sponsors in the open-angle glaucoma clinical trials market?
The leading sponsors in the diastolic heart failure trials market are Alcon Inc, AbbVie Inc, Santen Pharmaceutical Co Ltd, Aerie Pharmaceuticals Inc, Pfizer Inc, Merck & Co Inc, Bausch Health Companies Inc, Senju Pharmaceutical Co Ltd, Novartis AG, and Kowa Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Ophthalmology reports

